| Teva Pharma AG - Dasatinib-Teva 100 mg, Filmtabletten | | 67100 | | 05 | | Dasatinib-Teva 100 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 03.05.2019 | | |
| | Composition | | dasatinibum 100 mg ut dasatinibum monohydricum, lactosum monohydricum 131.307 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 1.44 mg, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Dasatinib | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dasatinib | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 131.307 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| |
|
